Hongene Biotechnology
PrivateLast Round
Grant
Oct 1, 2025
Total Funding Raised
$1.23M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Hongene Biotechnology operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Grant round in October 2025.
Hongene Biotechnology is a biotechnology company that provides nucleic acid raw materials and contract development and manufacturing organization (CDMO) services for the pharmaceutical and biotech industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hongene Biotechnology Comparables
Compare Hongene Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioSpring GmbH | 85% | |
| Innovassynth Technologies (India) Ltd | 84% | |
| ST Pharm Co.,Ltd | 80% |
For institutional investors. Book with your work email.
Hongene Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2025 | ||||
| Private Equity | May 24, 2020 |
For institutional investors. Book with your work email.
Hongene Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Private Equity |
| 中信金石投资有限公司 | Private Equity |
| Huasheng Capital | Private Equity |
| Bill & Melinda Gates Foundation | Grant |
| Addor Capital | Private Equity |
| CITIC Securities Investment | Private Equity |
| HongShan Capital Group (HSG) | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 11, 16% of headcount.
- Nov 11, 2025
Attended the 13th international mRNA health conference.
For institutional investors. Book with your work email.
Hongene Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hongene Biotechnology's valuation, stock price, and market status.
Is Hongene Biotechnology a public or private company?
Hongene Biotechnology is a private company.
What is the current stock price of Hongene Biotechnology?
Hongene Biotechnology is a private company, so its shares have no public market price. Caplight tracks Hongene Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hongene Biotechnology worth (valuation)?
Valuation information for Hongene Biotechnology is not publicly available.
Can I buy Hongene Biotechnology stock?
Hongene Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hongene Biotechnology's last funding round?
Hongene Biotechnology's most recent funding round was Grant on October 1, 2025.
Who are the main investors in Hongene Biotechnology?
Key investors in Hongene Biotechnology include Bill & Melinda Gates Foundation.
Will Hongene Biotechnology IPO soon?
No public IPO plans have been announced for Hongene Biotechnology.
How can I track Hongene Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Hongene Biotechnology's shares on secondary markets.